Concepts (62)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Exosome Multienzyme Ribonuclease Complex | 1 | 2023 | 9 | 0.820 |
Why?
|
| RNA, Long Noncoding | 1 | 2023 | 231 | 0.660 |
Why?
|
| RNA-Binding Proteins | 1 | 2023 | 551 | 0.610 |
Why?
|
| Mutagens | 2 | 2016 | 48 | 0.580 |
Why?
|
| Deoxyguanosine | 2 | 2016 | 12 | 0.500 |
Why?
|
| Breast Neoplasms | 3 | 2023 | 2653 | 0.460 |
Why?
|
| Smoking | 2 | 2015 | 928 | 0.380 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2023 | 41 | 0.200 |
Why?
|
| Telomere | 1 | 2023 | 220 | 0.180 |
Why?
|
| SUMO-1 Protein | 1 | 2020 | 8 | 0.170 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2020 | 256 | 0.140 |
Why?
|
| Receptors, Androgen | 1 | 2020 | 419 | 0.130 |
Why?
|
| Endopeptidases | 1 | 2017 | 108 | 0.130 |
Why?
|
| Pyrethrins | 1 | 2016 | 9 | 0.120 |
Why?
|
| Sister Chromatid Exchange | 1 | 2016 | 15 | 0.120 |
Why?
|
| Mammary Glands, Human | 1 | 2017 | 81 | 0.120 |
Why?
|
| Insecticides | 1 | 2016 | 47 | 0.120 |
Why?
|
| beta Catenin | 1 | 2017 | 209 | 0.120 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2016 | 139 | 0.110 |
Why?
|
| Lymphocytes | 1 | 2016 | 359 | 0.110 |
Why?
|
| Socioeconomic Factors | 2 | 2015 | 895 | 0.110 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2016 | 217 | 0.110 |
Why?
|
| Aspirin | 1 | 2016 | 216 | 0.110 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2017 | 611 | 0.100 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2016 | 274 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 792 | 0.100 |
Why?
|
| Oxidative Stress | 1 | 2016 | 810 | 0.090 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2012 | 93 | 0.090 |
Why?
|
| Cross-Sectional Studies | 2 | 2015 | 3843 | 0.070 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3453 | 0.070 |
Why?
|
| Female | 6 | 2023 | 71316 | 0.070 |
Why?
|
| Biomarkers | 1 | 2015 | 3415 | 0.060 |
Why?
|
| Signal Transduction | 1 | 2017 | 4693 | 0.050 |
Why?
|
| Humans | 7 | 2023 | 131967 | 0.050 |
Why?
|
| Young Adult | 2 | 2015 | 10108 | 0.050 |
Why?
|
| Sumoylation | 1 | 2020 | 41 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2020 | 209 | 0.040 |
Why?
|
| Adolescent | 2 | 2016 | 21008 | 0.040 |
Why?
|
| Adult | 3 | 2016 | 31734 | 0.040 |
Why?
|
| Proteolysis | 1 | 2020 | 195 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2020 | 646 | 0.040 |
Why?
|
| Cell Movement | 1 | 2020 | 886 | 0.030 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2017 | 69 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2016 | 239 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2020 | 825 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2016 | 275 | 0.030 |
Why?
|
| Child | 1 | 2015 | 26332 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 1626 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2017 | 900 | 0.020 |
Why?
|
| Male | 2 | 2016 | 65357 | 0.020 |
Why?
|
| Jordan | 1 | 2012 | 9 | 0.020 |
Why?
|
| Tobacco Products | 1 | 2012 | 61 | 0.020 |
Why?
|
| Maternal Exposure | 1 | 2012 | 149 | 0.020 |
Why?
|
| Attitude to Health | 1 | 2012 | 251 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2016 | 2963 | 0.020 |
Why?
|
| Urban Population | 1 | 2012 | 281 | 0.020 |
Why?
|
| Rural Population | 1 | 2012 | 260 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2017 | 2483 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 3708 | 0.020 |
Why?
|
| Family | 1 | 2012 | 593 | 0.020 |
Why?
|
| Pregnancy | 1 | 2012 | 7577 | 0.010 |
Why?
|
| Middle Aged | 1 | 2016 | 28911 | 0.010 |
Why?
|